GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C

Product NDC: 62032-130
11-digit product format: 620320130
Labeler code: 62032
Product ID: 62032-130_12532e36-5e7a-4fcb-a0d4-36819ae38ca5
Type: HUMAN OTC DRUG
Nonproprietary name: AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE
Dosage form: CREAM
Route: TOPICAL
Labeler: Obagi Medical Products, Inc., a division of Valeant Pharmaceuticals North America LLC.
Application: part352
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-11-04
Marketing end: 0000-00-00
Substance: AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE
Active strength: 30 mg/g; mg/g; mg/g; mg/g; mg/g
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	62032-130		I	Inactivated by FDA		2026-10-05
excluded package	package	62032-130	62032-130-70	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-130-70	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-130-70	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-130-70	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-130-70	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-130-70	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-130-70	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-130-70	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-130-70	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-130-70	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-130-70	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-130-70	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-130-70	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	62032-130-70	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	62032-130-70	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	62032-130-70	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	62032-130-70	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	62032-130-70	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	62032-130-70	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	62032-130-70	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	62032-130-70	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	62032-130-70	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	62032-130-70	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62032-130-70	2020-01-31	C162847	48780-1	9d75b9d0-9a8a-f424-e053-dadaa90a57ce	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C SUNSCREEN CREAM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-130-70	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C	48 g in 1 BOTTLE	CREAM	48		3
62032-130-70	GENTLE REJUVENATION SYSTEM	48 g in 1 BOTTLE	CREAM	48 g	80 mg in 1g	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
HOMOSALATE	ACTIVE INGREDIENT	V06SV4M95S	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OXYBENZONE	ACTIVE INGREDIENT	95OOS7VE0Y	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
HOMOSALATE	ACTIVE MOIETY	V06SV4M95S	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OXYBENZONE	ACTIVE MOIETY	95OOS7VE0Y	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
CITRUS MAXIMA FRUIT RIND	INACTIVE INGREDIENT	5NX3G75CA6	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
OCTOXYNOL-9	INACTIVE INGREDIENT	7JPC6Y25QS	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	2
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
HOMOSALATE	ACTIVE INGREDIENT	V06SV4M95S	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OXYBENZONE	ACTIVE INGREDIENT	95OOS7VE0Y	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
HOMOSALATE	ACTIVE MOIETY	V06SV4M95S	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OXYBENZONE	ACTIVE MOIETY	95OOS7VE0Y	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
CITRUS MAXIMA FRUIT RIND	INACTIVE INGREDIENT	5NX3G75CA6	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
DIMETHICONE 100	INACTIVE INGREDIENT	RO266O364U	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1
OCTOXYNOL-9	INACTIVE INGREDIENT	7JPC6Y25QS	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-130	GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) CREAM [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC.]	3	Legacy NDC, 1 package rows	20171219_787bf3c4-d7a6-44f8-a96c-75e3ae4f838f.zip
62032-130	GENTLE REJUVENATION SYSTEM (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI MEDICAL PRODUCTS, INC., A DIVISION OF VALEANT PHARMACEUTCALS NORTH AMERICA LLC.]	2	Legacy NDC	20171219_d1cd71bd-1e87-4aa9-9eee-ddb4d1274b8d.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
G63QQF2NOX	AVOBENZONE	70356-09-1	AVOBENZONE
V06SV4M95S	HOMOSALATE	118-56-9	HOMOSALATE
4X49Y0596W	OCTISALATE	118-60-5	OCTISALATE
5A68WGF6WM	OCTOCRYLENE	6197-30-4	OCTOCRYLENE
95OOS7VE0Y	OXYBENZONE	131-57-7	OXYBENZONE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
62032-130-70	62032013070	48 g in 1 BOTTLE	48 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GENTLE REJUVENATION FORTIFIED SUNSCREEN BROAD SPECTRUM SPF 30 WITH VITAMIN C SUNSCREEN CREAM	Obagi Medical Products, Inc., a division of Valeant Pharmaceuticals North America LLC. \| Swiss-American CDMO, LLC	2017-12-19	HUMAN OTC DRUG LABEL	3
GENTLE REJUVENATION SYSTEM	Obagi Medical Products, Inc., a division of Valeant Pharmaceutcals North America LLC. \| LABORATOIRE DR RENAUD INC. \| Swiss-American CDMO, LLC	2017-12-19	HUMAN OTC DRUG LABEL	2